25 September 2026
BASF, the world's biggest chemicals maker, has knocked on rival Evonik's door
Germany's BASF made a nonbinding takeover approach to smaller rival Evonik. Evonik confirmed it but says no talks are happening now; its shares jumped 7.2%.
The world's largest chemicals company wants to get bigger. BASF has approached fellow German chemicals group Evonik about a takeover, the FT reported, and both companies confirmed there has been contact. Nothing is agreed.
What happened
BASF recently put a merger proposal to Evonik and to its largest shareholder, the RAG-Stiftung foundation, which owns about 44% of Evonik. Evonik said the approach was nonbinding, meaning it is an expression of interest rather than a firm offer, and that no talks are currently taking place. BASF said it had held exploratory talks and the outcome was still open.
The numbers are large. Evonik's stock market value is about €8.4 billion, and about €12 billion once its net debt is included. Buyers usually have to pay a premium, an amount above the current share price, to win over shareholders. BASF itself is worth about €45 billion. Together the two had €74 billion of revenue last year.
Investors reacted fast. Evonik shares rose as much as 10.6% on Friday and closed up 7.2%. BASF fell 3.6%, a common pattern when a buyer might pay up.
Why it matters
European chemicals makers are under pressure. Energy costs have jumped because of the conflict in the Middle East, and there is too much production capacity worldwide. BASF has been selling side businesses, including a majority of its car-coatings unit to Carlyle for €7.7 billion, and cutting jobs. Evonik, which makes additives for things like paint and mattress foam, said this week it will cut more than 3,200 jobs.
For US investors, the point is competition. A combined German group could be better placed to take on Chinese rivals like Sinopec and American ones like Dow. Not everyone is convinced: a Berenberg analyst questioned whether buying Evonik fits BASF's plan to simplify, calling it possibly an interesting idea "at the wrong time."
What to watch
- Whether RAG-Stiftung backs a deal, since its 44% stake makes it the key vote.
- The size of any premium BASF offers over Evonik's share price.
- European competition regulators, who would review any merger.
Based on reporting by the Financial Times: BASF makes takeover approach for chemicals rival Evonik. Facts, not advice.
More news
- Anthropic's IPO, in numbers: 825 million shares at $70 to $78, and a $1.4 trillion price tag
- Trump says the Nvidia scandal didn't endanger US security, and stands by Lutnick
- Nvidia's first earnings without Huang: what Kress will be asked on Tuesday
- Buffett gives away $5.5 billion of Berkshire stock in his Thanksgiving letter
- Banks are using AI to trim back offices. Proof that it adds revenue is harder to find
- IMF chief says the world economy leans too hard on AI as circular deals top $1 trillion